44610-4 |
Heart rate |
NRat |
Capillary bed |
Episode^min |
Qn |
Oximetry |
|
DEPRECATED |
Deprecated Heart rate Episode minimum by Oximetry |
|
DEL |
DefinitionDescription |
|
|
beats/min |
|
|
|
|
|
|
HRTRATE.MOLEC |
|
44610-4 |
|
Oximetry |
|
|
Observation |
|
|
|
0 |
Deprecated Heart rate Episode Min Oximet |
|
|
|
N |
|
Count/time; Heart beat; HEART RATE.MOLEC; Minimal; minimum; nRate; Number rate; Number Rate = Count/Time; Pulse; QNT; Quan; Quant; Quantitative |
2.54 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44611-2 |
Heart rate |
NRat |
Capillary bed |
Episode^mean |
Qn |
Oximetry |
|
DEPRECATED |
Deprecated Heart rate Episode mean by Oximetry |
|
DEL |
DefinitionDescription |
|
|
beats/min |
|
|
|
|
|
|
HRTRATE.MOLEC |
|
44611-2 |
|
Oximetry |
|
|
Observation |
|
|
|
0 |
Deprecated Heart rate Episode Mean Oxime |
|
|
|
N |
|
Average; Avg; Count/time; Heart beat; HEART RATE.MOLEC; nRate; Number rate; Number Rate = Count/Time; Pulse; QNT; Quan; Quant; Quantitative |
2.54 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44612-0 |
Oxygen saturation |
MFr |
BldC |
Episode^max |
Qn |
Oximetry |
|
DEPRECATED |
Deprecated Oxygen saturation (Episode maximum) in Capillary blood Oximetry |
|
DEL |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEMODYN.MOLEC |
|
44612-0 |
|
Oximetry |
|
|
Observation |
|
|
|
0 |
Deprecated SaO2 Episode Max % BldC Oxime |
|
|
|
N |
|
Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Finger stick; Hemodynamics; HEMODYNAMICS.MOLEC; Mass Fraction; Maximum; O2; Percent; QNT; Quan; Quant; Quantitative; SaO2; SAT; Satn; SO2; tO2 |
2.54 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44613-8 |
Oxygen saturation |
MFr |
BldC |
Episode^min |
Qn |
Oximetry |
|
DEPRECATED |
Deprecated Oxygen saturation (Episode minimum) in Capillary blood Oximetry |
|
DEL |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEMODYN.MOLEC |
|
44613-8 |
|
Oximetry |
|
|
Observation |
|
|
|
0 |
Deprecated SaO2 Episode Min % BldC Oxime |
|
|
|
N |
|
Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Finger stick; Hemodynamics; HEMODYNAMICS.MOLEC; Mass Fraction; Minimal; minimum; O2; Percent; QNT; Quan; Quant; Quantitative; SaO2; SAT; Satn; SO2; tO2 |
2.54 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44614-6 |
Oxygen saturation |
MFr |
BldC |
Episode^mean |
Qn |
Oximetry |
|
DEPRECATED |
Deprecated Oxygen saturation in Episode mean Capillary blood by Oximetry |
|
DEL |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEMODYN.MOLEC |
|
44614-6 |
|
Oximetry |
|
|
Observation |
|
|
|
0 |
Deprecated SaO2 Episode Mean % BldC Oxim |
|
|
|
N |
|
Average; Avg; Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Finger stick; Hemodynamics; HEMODYNAMICS.MOLEC; Mass Fraction; O2; Percent; QNT; Quan; Quant; Quantitative; SaO2; SAT; Satn; SO2; tO2 |
2.54 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44615-3 |
Device error code |
Prid |
{Device} |
Pt |
Nom |
|
|
ACTIVE |
Device error code [Identifier] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEMODYN.MOLEC |
|
44615-3 |
|
|
|
|
Observation |
|
|
|
0 |
Device error code |
|
|
|
N |
|
Hemodynamics; HEMODYNAMICS.MOLEC; Identity or presence; Nominal; Point in time; Random |
2.27 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44616-1 |
Pulse oximetry panel |
- |
Capillary bed+BldC |
Pt |
Qn |
Oximetry |
|
DEPRECATED |
Deprecated Pulse oximetry panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CV |
|
44616-1 |
|
Oximetry |
|
|
Order |
|
|
|
0 |
Deprecated Pulse oximetry Pnl |
|
|
|
N |
|
Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Finger stick; Pan; Panl; Pnl; Point in time; Pulse oximetry Pnl; QNT; Quan; Quant; Quantitative; Random |
2.68 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44617-9 |
PWS gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
PWS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
44617-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
PWS gene Mut Anl Bld/T |
|
|
|
N |
|
15q11-13; Blood; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Prader Willi syndrome; Prader-Willi syndrome chromosome region; PWS; Random; SNRPN; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.63 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Based on LOINC Committee review (June 2016), "targeted" was added to the Component to clarify that this test is looking for a specific set of mutations as described in the LOINC User Guide under the Molecular Genetics section. |
0 |
44618-7 |
Total linear mm of carcinoma |
Len |
Specimen |
Pt |
Qn |
|
|
ACTIVE |
Total linear mm of carcinoma |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44618-7 |
|
|
|
|
Observation |
|
|
|
0 |
Total len of Ca |
|
|
|
N |
|
Length; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Tot; Total len of Ca; Totl |
2.7 |
2.17 |
|
|
|
|
|
|
|
mm |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
44619-5 |
Length of tissue core(s) |
Len |
Specimen |
Pt |
Qn |
|
|
ACTIVE |
Length of tissue core(s) |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
PATH.PROTOCOLS.GENER |
|
44619-5 |
|
|
|
|
Observation |
|
|
|
0 |
Length of tissue core(s) |
|
|
|
N |
|
Len; Length; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS general; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Spec |
2.7 |
2.17 |
|
|
|
|
|
|
|
mm |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
4462-8 |
Xylose.PO |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Xylose.PO [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
g |
|
|
|
|
|
|
DRUGDOSE |
|
4462-8 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose PO Dose |
|
|
|
Y |
|
Dose med or substance; DRUG DOSES; D-xylose; Point in time; QNT; Quan; Quant; Quantitative; Random; Xylose PO |
2.73 |
1 |
|
|
|
|
|
|
|
g |
|
|
|
0 |
44620-3 |
Other quantitation |
Find |
Specimen |
Pt |
Nar |
CAP cancer protocols |
|
DEPRECATED |
Deprecated Other quantitation by CAP cancer protocols |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44620-3 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Deprecated Other quantitation CAP prot |
|
|
|
N |
|
CAP prot; Finding; Findings; Narrative; Othr; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; Random; Report; Spec |
2.61 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44621-1 |
Regional lymph nodes examined |
Num |
Specimen |
Pt |
Qn |
CAP cancer protocols |
|
DEPRECATED |
Deprecated Regional lymph nodes examined by CAP cancer protocols |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44621-1 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Deprecated Reg LN examined CAP prot |
|
|
|
N |
|
CAP prot; Cnt; Count; LN exam; Number; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; QNT; Quan; Quant; Quantitative; Random; Reg LN examined; Spec |
2.69 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44622-9 |
Regional lymph nodes containing metastases |
Num |
Specimen |
Pt |
Qn |
CAP cancer protocols |
|
DEPRECATED |
Deprecated Regional lymph nodes containing metastases by CAP cancer protocols |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.SKIN |
|
44622-9 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Deprecated Reg LN containing metastases |
|
|
|
N |
|
CAP prot; Cnt; Count; Integument; Number; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS SKIN; Point in time; QNT; Quan; Quant; Quantitative; Random; Reg LN containing metastases; Spec |
2.69 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
44623-7 |
Matted nodes |
Prid |
Specimen |
Pt |
Nom |
CAP cancer protocols |
|
ACTIVE |
Matted nodes by CAP cancer protocols |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.SKIN |
|
44623-7 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Matted nodes CAP prot |
|
|
|
N |
|
CAP prot; Identity or presence; Integument; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS SKIN; Point in time; Random; Spec |
2.36 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44624-5 |
Additional pathological findings |
Find |
Tumor |
Pt |
Nom |
|
|
ACTIVE |
Additional pathological findings in Tumor |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.SKIN |
|
44624-5 |
|
|
|
|
Observation |
|
|
|
0 |
Addl path findings Tumor |
|
|
|
N |
|
Add; Addl path findings; Cancer; Finding; Findings; Integument; Nominal; Path; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS SKIN; Point in time; Random; tumors; tumour; tumours |
2.63 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Removed Method of "CAP cancer protocols" and the copyright since this is not a CAP-specific concept. |
0 |
44625-2 |
Periprostatic fat invasion |
Prid |
Specimen |
Pt |
Nom |
CAP cancer protocols |
|
ACTIVE |
Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.HISTO |
|
44625-2 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Periprost fat invasion Spec CAP prot |
|
|
|
N |
|
CAP prot; Identity or presence; Nominal; PATH.HISTO; PATHOLOGY; Periprost fat invasion; Point in time; Random; Spec |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44626-0 |
Seminal vesicle invasion |
Prid |
Specimen |
Pt |
Nom |
CAP cancer protocols |
|
ACTIVE |
Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.HISTO |
|
44626-0 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Seminal vesicle invasion Spec CAP prot |
|
|
|
N |
|
CAP prot; Identity or presence; Nominal; PATH.HISTO; PATHOLOGY; Point in time; Random; Spec |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44627-8 |
Extraprostatic extension |
Prid |
Prostate tumor |
Pt |
Nom |
CAP cancer protocols |
|
ACTIVE |
Extraprostatic extension by CAP cancer protocols |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.PROST |
|
44627-8 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Extraprostatic ext CAP prot |
|
|
|
N |
|
Cancer; CAP prot; EXT; Identity or presence; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS PROSTATE; Point in time; Prost; Prostatic; PrT; Random; tumors; tumour; tumours |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44628-6 |
Reason specimen size cannot be determined |
Find |
Breast tumor |
Pt |
Nar |
|
|
ACTIVE |
Reason specimen size cannot be determined in Breast tumor |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44628-6 |
|
|
|
|
Observation |
|
|
|
0 |
Reas spec size not det BT |
|
|
|
N |
|
Brst; BT; Cancer; Finding; Findings; Narrative; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Point in time; Random; Reas spec size not det; Report; Spec; tumors; tumour; tumours |
2.61 |
2.17 |
|
|
|
|
|
|
|
|
|
|
Updated Component from "Specimen size.cannot be determined" to clarify meaning, removed Method of CAP because this is not a CAP-specific term, and changed Property from Arb to Find. |
0 |
44629-4 |
Specimen size.max dimension |
Len |
Breast tumor |
Pt |
Qn |
|
|
ACTIVE |
Specimen size.maximum dimension in Breast tumor |
|
MIN |
DefinitionDescription |
|
|
cm |
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44629-4 |
|
|
|
|
Observation |
|
|
|
0 |
Spec size.max dim BT |
|
|
|
N |
|
Brst; BT; Cancer; Largest; Length; Maximal; Maximum; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Size.max.dim; Spec; Spec size.max dim; tumors; tumour; tumours |
2.7 |
2.17 |
|
|
|
|
|
|
|
cm |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
4463-6 |
Motility & count panel |
- |
Semen |
Pt |
- |
|
|
ACTIVE |
Spermatozoa motility and count panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.FERT |
|
4463-6 |
|
|
|
|
Order |
|
|
|
0 |
Motility + Cnt Pnl Smn |
|
|
|
Y |
|
Ejaculate; FERTILITY TESTING; Genitourinary; GU; Mot; Motility + Cnt Pnl; Pan; PANEL.FERTILITY; Panl; Pnl; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS; URO; Urology |
2.73 |
1 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
44630-2 |
Specimen size.additional dimension 1 |
Area |
Breast tumor |
Pt |
Qn |
|
|
ACTIVE |
Specimen size additional dimension 1 in Breast tumor |
|
MIN |
DefinitionDescription |
|
|
cm |
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44630-2 |
|
|
|
|
Observation |
|
|
|
0 |
Spec size addl dim 1 BT |
|
|
|
N |
|
Add; Brst; BT; Cancer; i; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Point in time; QNT; Quan; Quant; Quantitative; Random; Size addl dim; Spec; Spec size addl dim 1; tumors; tumour; tumours |
2.7 |
2.17 |
|
|
|
|
|
|
|
cm |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
44631-0 |
Specimen size.additional dimension 2 |
Area |
Breast tumor |
Pt |
Qn |
|
|
ACTIVE |
Specimen size additional dimension 2 in Breast tumor |
|
MIN |
DefinitionDescription |
|
|
cm |
|
|
|
|
|
|
PATH.PROTOCOLS.BRST |
|
44631-0 |
|
|
|
|
Observation |
|
|
|
0 |
Spec size addl dim 2 BT |
|
|
|
N |
|
Add; Brst; BT; Cancer; II; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS BREAST; Point in time; QNT; Quan; Quant; Quantitative; Random; Size addl dim; Spec; Spec size addl dim 2; tumors; tumour; tumours |
2.7 |
2.17 |
|
|
|
|
|
|
|
cm |
|
|
Removed method of "CAP cancer protocols" because this term is not a CAP cancer protocol-specific concept and can be used across various cancer protocols. |
0 |
44632-8 |
Satellite nodule presence |
Prid |
Skin melanoma |
Pt |
Nom |
CAP cancer protocols |
|
DEPRECATED |
Deprecated Satellite nodule presence by CAP cancer protocols |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH.PROTOCOLS.SKIN |
|
44632-8 |
|
CAP cancer protocols |
|
|
Observation |
|
|
|
0 |
Deprecated Satellite nodule presence CAP prot |
|
|
|
N |
|
CAP prot; Dermatologic; Epidermis; Identity or presence; Integument; Nominal; Pathology; PATHOLOGY PROTOCOLS; PATHOLOGY PROTOCOLS SKIN; Point in time; Random; Skn |
2.66 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |